ConductScience.org, home

Paper16337447

Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma.

Pearlman DS and 5 others. J Allergy Clin Immunol, 2005. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma. Papers, record 16337447. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16337447

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma.
PubMed
Journal
J Allergy Clin Immunol
PubMed
Year
2005
PubMed
Publication types
Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
1.74
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pearlman DSDavid S
2Berger WEWilliam E
3Kerwin EEdward
4Laforce CCraig
5Kundu SSudeep
6Banerji DDonald

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AsthmaMajor topic
PregnenedionesMajor topic
Adult
Double-Blind Method
Drug Administration Schedule
Female
Forced Expiratory Volume
Humans
Hydrocortisone
Male

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in16675356Ciclesonide inhalation aerosol for persistent asthma.https://conductscience.org/library/papers/16675356

Source PubMed

Download CSV of comments and corrections

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
38756322Eosinophilic Esophagitis: The Role of Steroids and the Dose, Duration, and Delivery of Steroid Therapy.Cureus2024https://conductscience.org/library/papers/38756322PubMed
28290122Scientific Rationale for Determining the Bioequivalence of Inhaled Drugs.Clin Pharmacokinet2017https://conductscience.org/library/papers/28290122PubMed
26221146Efficacy of Low-Dose Ciclesonide and Fluticasone Propionate for Mild to Moderate Persistent Asthma.Tanaffos2015https://conductscience.org/library/papers/26221146PubMed
25030199Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/25030199PubMed
22496679Ciclesonide in persistent asthma: the evidence of its therapeutic value.Core Evid2006https://conductscience.org/library/papers/22496679PubMed
22480537Successful treatment of eosinophilic esophagitis with ciclesonide.J Allergy Clin Immunol2012https://conductscience.org/library/papers/22480537PubMed
22386508Asthma outcomes: exacerbations.J Allergy Clin Immunol2012https://conductscience.org/library/papers/22386508PubMed
22382988Placebo effect model in asthma clinical studies: longitudinal meta-analysis of forced expiratory volume in 1 second.Eur J Clin Pharmacol2012https://conductscience.org/library/papers/22382988PubMed
21941441Profile of ciclesonide for the maintenance treatment of asthma.Ther Clin Risk Manag2011https://conductscience.org/library/papers/21941441PubMed
21437141Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma.J Asthma Allergy2009https://conductscience.org/library/papers/21437141PubMed
18728834New approaches to managing asthma: a US perspective.Ther Clin Risk Manag2008https://conductscience.org/library/papers/18728834PubMed
18681495Ciclesonide: a review of its use in the management of asthma.Drugs2008https://conductscience.org/library/papers/18681495PubMed
18425941Ciclesonide versus placebo for chronic asthma in adults and children.Cochrane Database Syst Rev2008https://conductscience.org/library/papers/18425941PubMed
18360579Ciclesonide for the treatment of asthma.Ther Clin Risk Manag2006https://conductscience.org/library/papers/18360579PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16337447

GET https://conductscience.org/api/papers/v1/16337447/authors